Ann Dermatol.  2014 Apr;26(2):275-277. 10.5021/ad.2014.26.2.275.

Levels of Serum Soluble P-Selectin and E-Selectin in Psoriatic Patients

• Ataseven A
• Ataseven H
• Ozturk P
• Ozdemir M
• Kesli R

• KMID: 2171675
• DOI: http://doi.org/10.5021/ad.2014.26.2.275

Abstract

No abstract available.

MeSH Terms

E-Selectin*
Humans
P-Selectin*
E-Selectin
P-Selectin

Figure

• 

  Fig. 1 Serum soluble P-selectin levels in the patient and control groups.

• 

  Fig. 2 Serum soluble E-selectin levels in the patient and control groups.

Reference

1. Diamantino F, Ferreira A. Future perspectives in the treatment of psoriasis: news in biological therapies. Acta Med Port. 2011; 24:997–1004.

2. Schön MP. Inhibitors of selectin functions in the treatment of inflammatory skin disorders. Ther Clin Risk Manag. 2005; 1:201–208.

3. Garbaraviciene J, Diehl S, Varwig D, Bylaite M, Ackermann H, Ludwig RJ, et al. Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis. Exp Dermatol. 2010; 19:736–741.

4. Tamagawa-Mineoka R, Katoh N, Kishimoto S. Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin. J Am Acad Dermatol. 2010; 62:621–626.

5. Ghalamkarpour F, Saeedi M, Hedayati M, Maarefat A. Soluble E-selectin and P-selectin serum levels in patients with psoriasis compared to healthy controls. Iran J Dermatol. 2010; 13:9–11.

6. Wakita H, Takigawa M. E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. Arch Dermatol. 1994; 130:457–463.

7. Bhushan M, Bleiker TO, Ballsdon AE, Allen MH, Sopwith M, Robinson MK, et al. Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial. Br J Dermatol. 2002; 146:824–831.

8. Czech W, Schöpf E, Kapp A. Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis--correlation with disease activity. Br J Dermatol. 1996; 134:17–21.

9. Groves RW, Kapahi P, Barker JN, Haskard DO, MacDonald DM. Detection of circulating adhesion molecules in erythrodermic skin disease. J Am Acad Dermatol. 1995; 32:32–36.

10. Bonifati C, Trento E, Carducci M, Sacerdoti G, Mussi A, Fazio M, et al. Soluble E-selectin and soluble tumour necrosis factor receptor (60 kD) serum levels in patients with psoriasis. Dermatology. 1995; 190:128–131.